Supernus Pharmaceuticals
SUPN
SUPN
225 hedge funds and large institutions have $1.33B invested in Supernus Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 73 increasing their positions, 83 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 209 → 225 (+16)
2.84% more ownership
Funds ownership: 97.62% → 100.46% (+2.8%)
12% less repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 83
Holders
225
Holding in Top 10
3
Calls
$4.77M
Puts
$1.35M
Top Buyers
| 1 | +$11.8M | |
| 2 | +$9.16M | |
| 3 | +$8.7M | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
+$6.86M |
| 5 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$5.76M |
Top Sellers
| 1 | -$6.88M | |
| 2 | -$5.14M | |
| 3 | -$3.78M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$3.74M |
| 5 |
BlackRock
New York
|
-$3.58M |